All about the Immuno Valley Annual Conference 2018: Bringing together innovators in science, technology and business. Looking forward to meeting you too!

We are delighted to invite you for the Immuno Valley Annual Conference, organised on 25 September 2018, at the Railway Museum, Utrecht, the Netherlands. At this Annual Conference we are also looking forward to celebrate our 10th Immuno Valley anniversary with you.

Infectious and inflammatory diseases are two of today's greatest medical challenges. While great achievements have been made in combatting these diseases over the past century, worldwide humans and animals are increasingly affected. This calls for new effective solutions!



Visit the Annual Conference 2018 website and check-out the preliminary programme, the speakers and the sponsors >>


  1. More news

  2. Micreos ‘Alternative to antibiotics’ winner of Ideas from Europe competition

    On April 26, 2018, Micreos was chosen as Europe’s most relevant innovation at the finals of the EU’s Ideas from Europe competition. Ideas from Europe is a European initiative that facilitates sustainable innovations aimed at global challenges.

  3. Proud to present our Annual Conference Speakers

    Top international speakers from academic institutions and businesses will let you explore developments and a forward look in diagnostics, prevention and treatment of inflammatory and infectious diseases in humans and animals .

  4. EXPLORA Consortium/Immuno Valley have entered the last phase of evaluation of 2017/2018 NWO ‘Perspectief’

    The EXPLORA Consortium focusses on personalized diagnostics and interventions in chronic inflammatory diseases.

  5. Successful 1st Immuno Valley Webinar for Partners delivered

    In May our first interactive Immuno Valley webinar took place about enhancing your success rate in NWO-TTW Perspectief. We look back on a successful webinar specially set-up for our partners.

  6. Immuno Valley welcomes 2 new partners

    Great news! We are welcoming two new Immuno Valley Partners: Ardol and Protinhi Therapeutics.